2025-12-01 Drugs Global Leadership for Increasing Patient Accessibility, SFDA Expands Lojuxta Indication to Include Treatment of Children with Homozygous Familial Hypercholesterolemia (HoFH)
2025-10-09 Drugs SFDA Approves the Registration of Qalsody for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
2025-09-01 Medical Devices SFDA Approves Innovative Biotechnology-Based Diagnostic Test for the Early Detection of Alzheimer's Disease
2025-08-28 Drugs SFDA Approves First-of-its-Kind Clinical Trial for a Gene Therapy Developed in Saudi Arabia to Treat Acute Lymphoblastic Leukemia (ALL)
2025-08-17 Drugs Saudi Innovation in Surgery: SFDA Grants Marketing Authorization for a Saudi-Made Medical Device
2025-08-12 Drugs The SFDA Approves the Registration of Elrexfio for the Treatment of Adults with Multiple Myeloma
2025-07-29 Drugs SFDA Approves the Registration of “Leqembi” as the First Alzheimer’s Treatment in Saudi Arabia
